Kwang Dong Pharmaceutical Co., Ltd.

KRX:009290.KS

5850 (KRW) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 36,965.56226,700.69925,540.74545,601.96722,655.80221,974.4223,083.08827,899.59536,083.16335,063.25721,998.58427,761.56329,893.84725,213.7123,185.82621,406.80924,162.48
Depreciation & Amortization 12,835.97814,017.13714,109.6719,708.75218,802.10917,451.61315,341.95714,592.18811,523.9697,598.3877,589.5347,499.5815,985.246,101.3127,713.7698,041.1258,361.679
Deferred Income Tax 0017,767.934967.47715,355.431000013,390.91813,713.5917,382.3315,717.5616,329.0235,368.28604,196.705
Stock Based Compensation 0017.586152.063212.061000019.8134.6574.274330.176200.64217.1080955.365
Change In Working Capital -69,201.3866,219.852-3,897.618-44,354.073-29,033.6856,138.385-24,983.065-21,265.975-20,571.159-23,685.823-9,643.828-19,089.074-13,697.625-7,138.681-10,209.538-18,980.675-1,403.842
Accounts Receivables -23,158.81617,540.592-15,922.34711,850.084-15,427.8714,849.583-13,681.41511,976.325-2,382.15600000000
Inventory -33,193.728-16,567.71115,152.962-31,271.725-37,180.264-6,659.278-21,979.413-19,968.597-5,472.991-4,270.461-13,005.078-14,577.996-9,278.93-7,391.075-3,307.291-9,803.708-5,841.505
Accounts Payables -7,213.34720,501.095-2,986.858-2,949.56715,615.2963,030.1378,830.63-4,297.3872,226.07600000000
Other Working Capital -5,635.495-15,254.124-141.375-21,982.8657,959.15312,797.663-3,003.652-1,297.378-15,098.168-19,415.3623,361.25-4,511.078-4,418.695252.394-6,902.247-9,176.9674,437.663
Other Non Cash Items 7,669.44115,884.3461,401.543752.5171,293.577,532.05410,022.8667,573.49314,107.952363.566601.644-390.406-550.293-0.265,838.501-17.142
Operating Cash Flow -11,730.40562,822.03454,939.8622,828.70329,285.28853,096.47223,464.84628,799.30141,143.92532,750.10534,394.12523,738.26927,678.90930,709.00426,275.19116,305.7636,255.245
Investing Activities:
Investments In Property Plant And Equipment -35,158.399-26,039.379-24,447.022-5,303.209-12,682.498-19,144.687-18,093.348-18,144.016-27,559.839-18,428.439-6,940.61-31,262.353-28,227.715-8,196.214-5,805.607-9,186.78-9,860.494
Acquisitions Net -21,213.301-2,898.711-2,261-1,270-287.031-1,891.879-2,762.0951,890.688-40,079.5542,053.066181.876144.382202.615101.999-216.88639.92372.419
Purchases Of Investments -630,925.884-708,644.631-505,585.079-336,200.592-209,652.563-379,795.173-282,508.495-178,047.037-247,223.32-131,755.922-98,317.337-81,331.978-193,632.046-112,544.126-127,092.961-74,423.471-46,945.571
Sales Maturities Of Investments 616,343.352693,646.943488,853.548270,408.815203,993.654371,511.879281,650.363176,031.563247,320.548128,127.17684,773.82586,877.128188,540.215109,716.39122,676.41268,690.14542,416.396
Other Investing Activites 133.2381,189.213463.62724,804.764838.5288,959.789-2,420.022-667.745-792.842-3,011.895-58.532-15,025.856-727.308546.571-684.102-1,234.89-748.94
Investing Cash Flow -70,820.995-42,746.565-42,975.927-47,560.222-17,789.909-20,360.072-24,133.597-18,936.546-68,335.007-23,016.015-20,360.778-40,598.678-33,844.239-10,375.38-11,123.144-16,115.073-15,066.19
Financing Activities:
Debt Repayment -69,000-114,000-116,000.1-106,833.38-165,133.28-142,845.224-91,558.225-39,767.594-114,528.773-23,830.31-14,211.787-13,612.874-2,430.21-7,247.79-36,936.34-10,800.245-10,161.125
Common Stock Issued -2,666.8090-85.549,525169,685.424134,200.392001,395.8851,487.937256.53258,329.0281,0005,257.20635,648.0559,578.17310,169.167
Common Stock Repurchased -6,234.892085.540-4,319.8-2,786.12600141,234.956-13,459.4572,930.405-8,294.092-6,271.715-5,826.459-995.362-3,347.574-6,757.122
Dividends Paid -4,107.878-4,107.878-4,107.875-3,166.3-3,214.302-3,246.146-3,246.449-3,246.297-3,213.914-2,875.943-2,448.599-2,131.755-2,231.754-2,331.754-2,347.186-2,888.005-2,479.745
Other Financing Activities 139,010117,479.62136,001.735104,312.514-223.5121,592.55101,462.8638,705.31730.46431,402.88495.971-739.746-2651,100.783342.999-2,158.473-4,373.546
Financing Cash Flow 57,000.422-628.25815,893.763,837.834-3,205.47-13,084.5546,658.186-4,308.57424,918.619-7,274.889-13,377.47833,550.561-10,198.678-9,048.014-4,287.834-9,616.124-13,602.371
Other Information:
Effect Of Forex Changes On Cash -656.999139.3551,226.448-504.966507.676228.912-1,077.973222.3421.061-35.013-98.227-137.093142.7580000
Net Change In Cash -26,207.97719,586.56729,084.141-21,398.6528,797.58419,880.7594,911.4635,776.521-2,251.4022,424.189557.64216,553.059-16,221.2511,285.6110,864.213-9,425.4377,586.684
Cash At End Of Period 77,344.257103,552.23483,965.66754,881.52676,280.17867,482.59447,601.83542,690.37336,913.85139,165.25336,741.06436,183.42119,675.63434,927.04623,641.43612,777.22322,202.66